Biomedical Devices—Applications for Disease Treatment and Tissue Regeneration

Dear Colleagues,

This Special Issue, “Biomedical Devices—Applications for Disease Treatment and Tissue Regeneration”, will focus on using biomedical devices and biomaterials for the treatment of degenerative disorders.  It will focus on the use of biomaterials and biochips targeting disease treatments and tissue regeneration. 

Mesenchymal stem cell therapy based on nanotechnology, pharmacophore encapsulation in nanomaterials and drug delivery systems, tissue engineering, and the use of "smart biomedical devices" to deliver bioactive signals for tissue regeneration are all examples of contemporary approaches to treating diseases.

It will involve three approaches, often in combination with each other: (a) therapies using tissue-regenerating cells, (b) therapies using growth factors that promote tissue cell proliferation and differentiation, and (c) therapies using biocompatible scaffolds.

Within this Special Issue, we will discuss current advances in biomaterials, biomedical device research, tissue engineering applications, drug delivery systems, nanotechnology-based disease detection systems, and the development of innovative therapeutic approaches using biomaterials.

This Special Issue is open for the submission of basic and clinical research, or that taking a multidisciplinary approach, and will also cover original articles and reviews on the following topics:

• Novel therapeutic approaches including biomedical devices.
• Biomaterial-based mesenchymal stem cell therapy.
• Bioactive signal delivery for mesenchymal stem cell differentiation.
• Application of biomedical applications in osteogenesis, chondrogenesis, angiogenesis, neurogenesis, etc.
• Clinical trials/research on biomedical devices.
• Tissue engineering.
• Cancer.

Dr. Eleni Papachristou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.